[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340528-105":59,"doc-detail-340528-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","non-rb1-germline-cancer-predisposing-variants-found-in-retinoblastoma-patients","Non-RB1 germline cancer predisposing variants found in retinoblastoma patients","","Hereditary retinoblastoma is linked to lifelong elevated risk for subsequent malignant neoplasms, but the contribution of non-RB1 germline variants to tumorigenesis and SMN risk remains insufficiently characterized. This brief report retrospectively analyzes 94 retinoblastoma individuals with prior next-generation sequencing germline testing to determine the frequency and spectrum of non-RB1 cancer-predisposing variants and their clinical associations, including time to SMN. Non-RB1 variants were identified, yet did not show evidence of augmenting tumorigenesis or progression in this cohort.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/non-rb1-germline-cancer-predisposing-variants-found-in-retinoblastoma-patients/340528/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/non-rb1-germline-cancer-predisposing-variants-found-in-retinoblastoma-patients/340528.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does this study address regarding retinoblastoma and cancer risk?","Question",{"text":112,"@type":113},"It evaluates whether non-RB1 germline cancer predisposition variants influence tumorigenesis, disease progression, and subsequent malignant neoplasm (SMN) risk in individuals with retinoblastoma.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were participants and germline data collected?",{"text":117,"@type":113},"The study retrospectively collected data from institutional electronic medical records for 94 retinoblastoma individuals who previously underwent NGS germline analysis using the MSK-IMPACT platform.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main findings about non-RB1 variants and SMN risk?",{"text":121,"@type":113},"In this small cohort, non-RB1 variants did not appear to augment tumorigenesis or disease progression; larger studies are needed to assess associations between specific variants and SMN development.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340528,1790127872,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","Genetics in Medicine Open (2024) 2, 101836  \n[www.journals.elsevier.com/genetics-in-medicine-open](www.journals.elsevier.com/genetics-in-medicine-open)  \nBRIEF REPORT  \nNon-RB1 germline cancer predisposing variants found in retinoblastoma patients  \nAna Maria Rodriguez Barreto 1, * , Michael F. Walsh 1, 2 , Melissa A. Robbins 2,3 , Audrey Mauguen4 , Elise M. Fiala 1, 2 , Cristina Olcese2,3 , Dianna Haggag-Lindgren3 , Diana Mandelker3, 5 , Jasmine H. Francis3, 6 , Michael F. Berger5 ,  \nDanielle Novetsky Friedman 1 , Kenneth Ofﬁt2 , David H. Abramson 2,3, 5,6  \n1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; 2Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY; 3Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY; 4Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY; 5Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY; 6Department of Ophthalmology, Weill Cornell Medical Center, New York, NY  \n\n| ARTICL E I NFO | A B S T R A C T |\n| --- | --- |\n| Article history: | Purpose: It is well known that individuals with hereditary retinoblastoma are at lifelong high |\n| Received 28 May 2023 | risk for developing subsequent malignant neoplasms (SMN) . However, the role that non-RB1 |\n| Received in revised form | germline variants play in tumorigenesis and SMN risk has not yet been studied. The purpose of |\n| 4 March 2024 | this study is to report the frequency and spectrum of non-RB1 germline cancer predisposing |\n| Accepted 4 March 2024 | variants in individuals with retinoblastoma (RB) . |\n| Available online 6 March 2024 | Methods: Retrospective data collection from institutional electronic medical records of 94 individuals seen at our institution with personal history of retinoblastoma, who had undergone next-generation sequencing germline analysis. |\n| Keywords: |  |\n| Cancer | Results: The prevalence of individuals with cancer predisposition was 57%(54/94) . Of these |\n| Genetics | individuals, 76%(41/54) had a pathogenic/likely pathogenic (P/LP) variant only in the RB1 |\n| Germline cancer susceptibility | gene, 9%(5/54) harbored a P/LP variant only in a non-RB1 gene, and 11%(6/54) had both. No |\n| syndromes | difference was found between patients with and without non-RB1 variants when comparing |\n| Retinoblastoma | demographic and clinical characteristics, including time to SMN. Variants were found in 7 |\n| Secondary malignancies | different genes, with only 1 variant repeating 3 times.\u003Cbr>Conclusion: In this small cohort of patients with retinoblastoma, non-RB1 variants did not appear to augment tumorigenesis or disease progression. Larger studies are required to determine associations between speciﬁc variants and development of SMN. |\n|  | © 2024 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics. This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)). |\n\nThe Article Publishing Charge (APC) for this article was paid by the Memorial Sloan Kettering Cancer Center.  \n*Correspondence and requests for materials should be addressed to Ana Maria Rodriguez Barreto, 3100 SW 62nd Avenue, Genetics and Metabolism, 3rd  \nFloor Brain Institute, Miami, FL 33155-3009. Email address: [anamaria.rodriguezbarreto@nicklaushealth.org](anamaria.rodriguezbarreto@nicklaushealth.org)  \ndoi: [https://doi.org/10.1016/j.gimo.2024.101836](https://doi.org/10.1016/j.gimo.2024.101836)  \n2949-7744/© 2024 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics. This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \nIntroduction  \nIt is recognized that individuals with hereditary retinoblastoma","cbCaioWU1ZqVetPX","https://ap.wps.com/l/cbCaioWU1ZqVetPX","pdf",799638,"English","# Introduction\n# Materials and Methods\n# Results\n# Conclusion","[{\"question\":\"What question does this study address regarding retinoblastoma and cancer risk?\",\"answer\":\"It evaluates whether non-RB1 germline cancer predisposition variants influence tumorigenesis, disease progression, and subsequent malignant neoplasm (SMN) risk in individuals with retinoblastoma.\"},{\"question\":\"How were participants and germline data collected?\",\"answer\":\"The study retrospectively collected data from institutional electronic medical records for 94 retinoblastoma individuals who previously underwent NGS germline analysis using the MSK-IMPACT platform.\"},{\"question\":\"What were the main findings about non-RB1 variants and SMN risk?\",\"answer\":\"In this small cohort, non-RB1 variants did not appear to augment tumorigenesis or disease progression; larger studies are needed to assess associations between specific variants and SMN development.\"}]","Non-RB1 germline cancer predisposing variants found in retinoblastoma patients | PDF",1790037100,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc5b9476f8bd4cb844c2c76c0d05a0bd.webp",983,1336,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30b097da200733dd6d830500cac76a7d.webp",982,1334,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a093ccc669d829af06bdc18831431ab.webp",981,1333,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7c9ec4e2feb5029bb79af3d29ea2fec.webp",980,1332]